| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,003 |
3,681 |
$352K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,915 |
3,818 |
$332K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,889 |
1,817 |
$201K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,706 |
1,692 |
$188K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,542 |
3,421 |
$23K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,432 |
3,139 |
$8K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,144 |
3,078 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
616 |
536 |
$312.75 |
| 90473 |
|
418 |
412 |
$143.02 |
| 81003 |
|
717 |
689 |
$136.55 |
| 71046 |
Radiologic examination, chest; 2 views |
32 |
32 |
$104.66 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
41 |
35 |
$51.33 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
26 |
26 |
$49.24 |
| 81025 |
|
72 |
72 |
$43.02 |
| 99000 |
|
37 |
26 |
$10.26 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
298 |
290 |
$7.69 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
12 |
12 |
$0.05 |
| 73610 |
|
12 |
12 |
$0.00 |
| 99072 |
|
103 |
93 |
$0.00 |
| A9150 |
Non-prescription drugs |
1,059 |
651 |
$0.00 |